PHYSICOCHEMICAL AND BIOLOGICAL PROPERTIES OF ASSOCIATES OF COPPER NANOPARTICLES
- 作者: Borodulin V.B.1, Matasov A.D.2,3, Goroshinskaya I.A.4, Okunev I.S.2, Petrov S.N.5, Drozdova N.F.5, Kachesova P.S.4, Losev O.E.1, Bobyleva E.V.1, Zlatnik E.Y.4, Chebotareva E.G.1, Lazarenko Y.S.1, Bobylev A.V.1, Borodulina E.V.1
-
隶属关系:
- Saratov State Medical University, Russian Ministry of Health
- Konstantinov St. Petersburg Institute of Nuclear Physics
- Ioffe Institute
- Rostov Research Institute of Oncology, Russian Ministry of Health
- Prometey
- 期: 卷 14, 编号 1-2 (2019)
- 页面: 74-81
- 栏目: Nanobiomedicine and Nanopharmaceuticals
- URL: https://journals.rcsi.science/2635-1676/article/view/220724
- DOI: https://doi.org/10.1134/S1995078019010038
- ID: 220724
如何引用文章
详细
Abstract—The physicochemical parameters of associates of unstabilized copper nanoparticles (NPs) obtained by the plasma-chemical method were studied. Optical methods were used to determine the size of NP associates, including atomic force microscopy, spectrophotometry, and fluorometry. The sizes of copper NPs varied from 30 to 75 nm, and the sizes of NP associates, from 481.1 to 1037 nm. The phase composition of copper NPs was analyzed by X-ray diffractometry using a Rigaku Ultima IV multifunctional X-ray diffractometer. An oxide film without an admixture of organic molecules was found on the surface of NP associates. The effect of copper NPs on an A549 cell culture was studied. A change was observed in the biochemical parameters of blood serum of outbred mice under the influence of copper NPs. The antitumor effect of copper NPs was revealed, and its intensity was compared to different methods of administering NP to animals with fibrosarcoma (S-45) and Pliss lymphosarcoma.
作者简介
V. Borodulin
Saratov State Medical University, Russian Ministry of Health
编辑信件的主要联系方式.
Email: borodulinvb@mail.ru
俄罗斯联邦, Saratov
A. Matasov
Konstantinov St. Petersburg Institute of Nuclear Physics; Ioffe Institute
Email: borodulinvb@mail.ru
俄罗斯联邦, St. Petersburg; St. Petersburg
I. Goroshinskaya
Rostov Research Institute of Oncology, Russian Ministry of Health
Email: borodulinvb@mail.ru
俄罗斯联邦, Rostov-on-Don
I. Okunev
Konstantinov St. Petersburg Institute of Nuclear Physics
Email: borodulinvb@mail.ru
俄罗斯联邦, St. Petersburg
S. Petrov
Prometey
Email: borodulinvb@mail.ru
俄罗斯联邦, St. Petersburg
N. Drozdova
Prometey
Email: borodulinvb@mail.ru
俄罗斯联邦, St. Petersburg
P. Kachesova
Rostov Research Institute of Oncology, Russian Ministry of Health
Email: borodulinvb@mail.ru
俄罗斯联邦, Rostov-on-Don
O. Losev
Saratov State Medical University, Russian Ministry of Health
Email: borodulinvb@mail.ru
俄罗斯联邦, Saratov
E. Bobyleva
Saratov State Medical University, Russian Ministry of Health
Email: borodulinvb@mail.ru
俄罗斯联邦, Saratov
E. Zlatnik
Rostov Research Institute of Oncology, Russian Ministry of Health
Email: borodulinvb@mail.ru
俄罗斯联邦, Rostov-on-Don
E. Chebotareva
Saratov State Medical University, Russian Ministry of Health
Email: borodulinvb@mail.ru
俄罗斯联邦, Saratov
Ya. Lazarenko
Saratov State Medical University, Russian Ministry of Health
Email: borodulinvb@mail.ru
俄罗斯联邦, Saratov
A. Bobylev
Saratov State Medical University, Russian Ministry of Health
Email: borodulinvb@mail.ru
俄罗斯联邦, Saratov
E. Borodulina
Saratov State Medical University, Russian Ministry of Health
Email: borodulinvb@mail.ru
俄罗斯联邦, Saratov
补充文件
